Low LDL Cholesterol Associated with Parkinson’s Risk

It is a rather sad commentary on the American Heart Association’s and Big Pharma’s aggressive marketing of statin Class of drugs aka HMG-CoA reductase inhibitors, that are used to lower cholesterol levels by inhibiting the HMG-CoA reductase enzyme that plays a central role in liver function and cholesterol production. drugs that their abnormally low proposed levels of LDL cholesterol Low-density lipoprotein. It is a group of lipids and proteins that allow lipids like cholesterol, triglycerides, and fat soluble nutrients (Vitamin A, D, E , K, Q 10, carotenes) to be transported with the water-based bloodstream. for heart health (<90) are the very same levels associated with a new study’s findings for a significantly increased risk for

Parkinson’s disease¹. 

This is not terribly hard to figure out, since brain cells require cholesterol for longevity.  By age 70 the risk for Parkinson’s really increases, meaning the older a person gets who has too low of cholesterol the more likely they are to have serious nerve problems.  Of course, loss of memory, nerve transmission problems, depression, and even suicide are linked to statin Class of drugs aka HMG-CoA reductase inhibitors, that are used to lower cholesterol levels by inhibiting the HMG-CoA reductase enzyme that plays a central role in liver function and cholesterol production. use – problems that all get worse the longer statins are used.

Just as too much cholesterol is not good for overall health, neither is too little.  Cholesterol problems are best managed by getting cholesterol into a healthy range by being fit and eating well, and using dietary supplements as appropriate to maintain good health.  There is a huge difference between having cholesterol in a healthy range because you are healthy and having cholesterol levels drugged into a range.  It is now clear that levels that are too low over time increase the risk for serious nerve-related problems during aging.